EUCTR2004-001861-17-DKActive, not recruitingNot Applicable
EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL). - EURO-LB 02
OPHO-NHL GRUPP0 sites270 target enrollmentStarted: July 10, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 270
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •All newly diagnosed patients at the involved centers under the age of 18 years with a T-/pre B-cells non-Hodgkins lymphoma can be included.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •HIV infection or AIDS
- •previous organ transplantation
- •previous malignancy
- •pre-existing disease prohibiting chemotherapy as per se instructions of the Protocol
- •previous chemotherapy or radiotherapy
- •previous systemic corticosteroid treatment for more than 8 days withon two months before beginning the Euro protocol
Investigators
Similar Trials
Active, not recruiting
Not Applicable
EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL). - EURO-LB 02Multicenter randomised trial conducted in european countries and the five nordic countries on children up to the age of 18 years newly diagnosed with T-cell and and pre -B lymphoblastic lymphoma (T-LBL pre-B-LBL ). The current nordic protocol for treatment of this disease is very similar with new Euro protocol the main difference being to administer dexamethason in the begining of the treatment and not -as to day - 3 months later.EUCTR2004-001861-17-SEOPHO-NHL GRUPP270
Active, not recruiting
Phase 1
Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma(EICNHL) - Euro LB 02 protocolymphoblastic Lymphoma( malignant disease, pre B- and T cell lymphoma) in children up to 16 years.MedDRA version: 9.1Level: LLTClassification code 10036545Term: Precursor T-lymphoblastic lymphoma/leukaemia NOSMedDRA version: 9.1Level: LLTClassification code 10036525Term: Precursor B-lymphoblastic lymphoma NOSEUCTR2004-001861-17-NOniversity Hospital of Northern Norway. Department of Pediatrics600
Recruiting
Phase 2
Treatment protocol for adult acute lymphoblastic leukemia (-ALL/MRD2023-)acute lymphoblastic leukemiaJPRN-jRCTs071220071Koichi Akashi210
Completed
Phase 2
Treatment protocol for adult acute lymphoblastic leukemia -ALL/MRD2014acute lymphoblastic leukemiaJPRN-UMIN000012382Fukuoka Blood & Marrow Transplant Group100
Recruiting
Not Applicable
Treatment protocol for adult acute lymphoblastic leukemiaJPRN-UMIN000037626Japan Study Group for Cell Therapy and Transplantation200